Neonatal responses to alphaprodine administered during labor

Area of Science:

• Obstetrics and Gynecology
• Neonatal Pharmacology
• Anesthesiology

Background:

• Alphaprodine is an opioid analgesic used during labor.
• Potential effects of maternal medication on neonates require careful evaluation.
• Assessing neonatal outcomes is crucial for understanding drug safety during childbirth.

Purpose of the Study:

• To evaluate the effects of intravenous alphaprodine on neonatal outcomes.
• To compare Apgar scores, neonatal acid-base status, and NACS between neonates exposed to alphaprodine and those not exposed.
• To quantify maternal-fetal transfer of alphaprodine.

Main Methods:

• A comparative study involving 30 parturients divided into two groups: one receiving alphaprodine and a control group.
• Assessment of Apgar scores, neonatal acid-base status, and the Neurologic and Adaptive Capacity Scoring System (NACS).
• Gas-chromatographic mass spectrophotometry was used to measure alphaprodine concentrations in maternal and umbilical vessels.

Main Results:

• No significant differences were observed in Apgar scores, neonatal acid-base status, or NACS between the alphaprodine and control groups.
• The umbilical vein-to-maternal vein concentration ratio of alphaprodine was 0.52 +/- 0.09.
• Maternal administration of alphaprodine did not lead to adverse neonatal effects in this study.

Conclusions:

• Intravenously administered alphaprodine, at the dosage and timing used in this study, does not appear to have adverse effects on neonates.
• Alphaprodine demonstrates a transfer ratio across the placenta, but this did not correlate with negative neonatal outcomes.
• The findings support the safety of using alphaprodine during labor under the studied conditions.